The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Targeted Disruption of the Acid α-Glucosidase Gene in Mice Causes an Illness with Critical Features of Both Infantile and Adult Human Glycogen Storage Disease Type II
Open accessAbstract
We have used gene targeting to create a mouse model of glycogen storage disease type II, a disease in which distinct clinical phenotypes present at different ages. As in the severe human infantile disease (Pompe Syndrome), mice homozygous for disruption of the acid alpha-glucosidase gene (6(neo)/6(neo)) lack enzyme activity and begin to accumulate glycogen in cardiac and skeletal muscle lysosomes by 3 weeks of age, with a progressive increase thereafter. By 3.5 weeks of age, these mice have markedly reduced mobility and strength. They grow normally, however, reach adulthood, remain fertile, and, as in the human adult disease, older mice accumulate glycogen in the diaphragm. By 8-9 months of age animals develop obvious muscle wasting and a weak, waddling gait. This model, therefore, recapitulates critical features of both the infantile and the adult forms of the disease at a pace suitable for the evaluation of enzyme or gene replacement. In contrast, in a second model, mutant mice with deletion of exon 6 (Delta6/Delta6), like the recently published acid alpha-glucosidase knockout with disruption of exon 13 (Bijvoet, A. G., van de Kamp, E. H., Kroos, M., Ding, J. H., Yang, B. Z., Visser, P., Bakker, C. E., Verbeet, M. P., Oostra, B. A., Reuser, A. J. J., and van der Ploeg, A. T. (1998) Hum. Mol. Genet. 7, 53-62), have unimpaired strength and mobility (up to 6.5 months of age) despite indistinguishable biochemical and pathological changes. The genetic background of the mouse strains appears to contribute to the differences among the three models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1.
Sauer, B., & Henderson, N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5166 · Cited by 1,213
Self-citationEfficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125
Self-citationNeufeld, E. F. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.001353 · Cited by 900
Kessler, P. D., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P. C., Matelis, L. A., Kurtzman, G. J., & Byrne, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14082 · Cited by 614
Self-citationYamanaka, S., Johnson, M. D., Grinberg, A., Westphal, H., Crawley, J. N., Taniike, M., Suzuki, K., & Proia, R. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9975 · Cited by 209
Kikuchi, T., Yang, H. W., Pennybacker, M., Ichihara, N., Mizutani, M., Van Hove, J. L., & Chen, Y. T. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1722 · Cited by 167
Human lysosomal alpha-glucosidase. Characterization of the catalytic site
Hermans, M. M., Kroos, M. A., van Beeumen, J., Oostra, B. A., & Reuser, A. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92727-4 · Cited by 161
Glycogenosis type II (acid maltase deficiency)
Reuser, A. J. J., Kroos, M. A., Hermans, M. M. P., Bijvoet, A. G. A., Verbeet, M. P., van Diggelen, O. P., Kleijer, W. J., & van der Ploeg, A. T. (1995) · Muscle & Nerve · doi:10.1002/mus.880181414 · Cited by 161
Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease
Bijvoet, A. G. A., van de Kamp, E. H. M., Kroos, M. A., Ding, J. H., Yang, B.-Z., de Visser, P. J., Bakker, C. E., Verbeet, M. P., Oostra, B. A., Reuser, A. J. J., et al. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.1.53 · Cited by 143
Martiniuk, F. T., Mehler, M. F., Pellicer, À., Tzall, S., Badie, G., Hobart, C., Ellenbogen, A. L., & Hirschhorn, R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9641 · Cited by 112
Hove, J. L. V., Yang, H. W., Wu, J. Y., Brady, R. O., & Chen, Y. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.65 · Cited by 106
Mouse models of human genetic disease: Which mouse is more like a man?
Erickson, R. P. (1996) · BioEssays · doi:10.1002/bies.950181209 · Cited by 91
Genetic defects in patients with glycogenosis type II (acid maltase deficiency)
Raben, N., Nichols, R. C., Boerkoel, C. F., & Plötz, P. H. (1995) · Muscle & Nerve · doi:10.1002/mus.880181415 · Cited by 50
Self-citationZaretsky, J. Z., Candotti, F., Boerkoel, C. F., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.13-1555 · Cited by 41
Cited by
Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors
Zolotukhin, S., Potter, M., Zolotukhin, I., Sakai, Y., Loiler, S., Fraites, T. J., Chiodo, V. A., Phillipsberg, T., Muzyczka, N., Hauswirth, W. W., et al. (2002) · Methods · doi:10.1016/s1046-2023(02)00220-7 · Cited by 565
Self-citationLessons on the pathogenesis of aneurysm from heritable conditions
Lindsay, M. E., & Dietz, H. C. (2011) · Nature · doi:10.1038/nature10145 · Cited by 473
Raben, N., Hill, V., Shea, L., Takikita, S., Baum, R., Mizushima, N., Ralston, E., & Plotz, P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn292 · Cited by 352
Self-citationTranscription factor EB (TFEB) is a new therapeutic target for Pompe disease
Spampanato, C., Feeney, E., Li, L., Cardone, M., Lim, J., Annunziata, F., Zare, H., Polishchuk, R., Puertollano, R., Parenti, G., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202176 · Cited by 341
Self-citationEnzyme replacement and enhancement therapies: lessons from lysosomal disorders
Desnick, R. J., & Schuchman, E. H. (2002) · Nature Reviews Genetics · doi:10.1038/nrg963 · Cited by 268
Metadata
- Authors
- Raben, N., Nagaraju, K., Lee, E., Kessler, P., Byrne, B., Lee, L., LaMarca, M., King, C., Ward, J., Sauer, B., & Plotz, P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-07
- Volume
- 273
- Issue
- 30
- Pages
- 19086-19092
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2127608615
- Cited by
- 299
- References
- 14
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
